Guan-Liang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guan-Liang Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chia-Wen Tsai
Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan
1 shared publication - Da-Tian Bau
Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404333, Taiwan
1 shared publication - Ding-Han Chen
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung 404327, Taiwan
1 shared publication - Ko-Hsin Chu
Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung City, Taiwan (R.O.C.)
1 shared publication - Liang-Wen Hang
College of Medicine, China Medical University Taichung Taiwan
1 shared publication - Meng-Chiung Lin
Division of Gastroenterology and Hepatology Medicine, Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung, Taiwan (R.O.C.)
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2349
Association of the MMP12 rs652438 Variant with Lung Cancer Susceptibility: A Smoking-Stratified Analysis
Background: Matrix metalloproteinase 12 (MMP12) participates in extracellular-matrix remodeling and smoking-related pulmonary inflammation. This study evaluated the associations of MMP12 rs2276109 and rs652438 with lung cancer susceptibility in a Taiwanese population and examined rs652438 according to smoking status. Materials and Methods: This case–control study included 358 patients with histologically confirmed lung cancer and 716 age- and sex-matched cancer-free controls. Genotypes were determined using polymerase chain reaction–restriction fragment length polymorphism analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated under genotype, dominant, recessive, and allele models. Smoking-stratified estimates were adjusted for age and sex. Results: rs2276109 was not associated with lung cancer susceptibility. For rs652438, the CC genotype was associated with higher odds of lung cancer than the TT genotype (OR = 4.68, 95% CI = 2.00–10.99, p = 0.0003). Associations were also observed under the recessive (OR = 4.41, 95% CI = 1.89–10.32) and dominant (OR = 1.51, 95% CI = 1.12–2.03) models. The C allele was associated with higher lung cancer odds (OR = 1.62, 95% CI = 1.25–2.11). Among ever-smokers, the CC genotype remained associated with lung cancer after adjustment for age and sex (adjusted OR = 5.63, 95% CI = 2.17–15.38), whereas no significant association was observed among non-smokers. Conclusions:MMP12 rs652438, but not rs2276109, was associated with lung cancer susceptibility in this Taiwanese population. The association was more apparent among ever-smokers, although formal genotype-smoking interaction analyses were not statistically significant. Independent replication and functional investigation are warranted.
- 15 October 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (10) , 2349
Open AccessAssociation of the MMP12 rs652438 Variant with Lung Cancer Susceptibility: A Smoking-Stratified Analysis
Background: Matrix metalloproteinase 12 (MMP12) participates in extracellular-matrix remodeling and smoking-related pulmonary inflammation. This study evaluated the associations of MMP12 rs2276109 and rs652438 with lung cancer susceptibility in a Taiwanese population and examined rs652438 according to smoking status. Materials and Methods: This case–control study included 358 patients with histologically confirmed lung cancer and 716 age- and sex-matched cancer-free controls. Genotypes were determined using polymerase chain reaction–restriction fragment length polymorphism analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated under genotype, dominant, recessive, and allele models. Smoking-stratified estimates were adjusted for age and sex. Results: rs2276109 was not associated with lung cancer susceptibility. For rs652438, the CC genotype was associated with higher odds of lung cancer than the TT genotype (OR = 4.68, 95% CI = 2.00–10.99, p = 0.0003). Associations were also observed under the recessive (OR = 4.41, 95% CI = 1.89–10.32) and dominant (OR = 1.51, 95% CI = 1.12–2.03) models. The C allele was associated with higher lung cancer odds (OR = 1.62, 95% CI = 1.25–2.11). Among ever-smokers, the CC genotype remained associated with lung cancer after adjustment for age and sex (adjusted OR = 5.63, 95% CI = 2.17–15.38), whereas no significant association was observed among non-smokers. Conclusions:MMP12 rs652438, but not rs2276109, was associated with lung cancer susceptibility in this Taiwanese population. The association was more apparent among ever-smokers, although formal genotype-smoking interaction analyses were not statistically significant. Independent replication and functional investigation are warranted.
- Open Access
- 14 August 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Afatinib-associated pancreatitis in a patient with lung cancer– A rare case report
- 14 August 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessAfatinib-associated pancreatitis in a patient with lung cancer– A rare case report